NK cells are considered as crucial members of the complex immune response: in the primary immune response, via directly making lysis of cancer cells through the ADCC pathway and removing MHC-damaged cells; for the secondary adaptive immune response, by priming the tumor microenvironment via inducing PD-L1 expression on tumors and the recruitment of DCs and T cells. The gene discussed is HLA-C; the disease is neoplasm.